Literature DB >> 23278319

Higher glutamate to glutamine ratios in occipital regions in women with migraine during the interictal state.

Jesús González de la Aleja1, Ana Ramos, Virginia Mato-Abad, Antonio Martínez-Salio, Juan A Hernández-Tamames, José Antonio Molina, Jesús Hernández-Gallego, Juan Alvarez-Linera.   

Abstract

BACKGROUND: Glutamate (Glu) and glutamine (Gln) are strongly compartmentalized (in neurons for Glu and in astrocytes for Gln). The visual cortex is the brain region with a higher neuron/astrocyte ratio (the highest neuronal density and the relatively lowest density of astrocytes). Elevations in extracellular Glu or potassium above certain thresholds are likely candidates to be the final common steps in the multiple distinct processes that can lead to cortical spreading depression. Astrocytes play a key role in this phenomenon, by acting as a sink for extracellular Glu and potassium, as well as generally acting as a buffer for the ionic and neurochemical changes that initiate and propagate cortical spreading depression.
OBJECTIVE: The purpose of this study was to quantify Glu and Gln to generate Glu/Gln ratios in women with migraine during the interictal state compared with healthy control women.
METHODS: Twenty-seven patients with migraine (8 with aura and 19 without aura) and 19 matched healthy controls were included in the study. We performed proton magnetic resonance spectroscopy in the anterior paracingulate cortex and occipital cortex (OC). Spectral analysis was performed by LCModel, allowing a separation of Glu and Gln using a 3T machine.
RESULTS: The main result was a significantly higher Glu/Gln ratio in the OC of migraine patients compared with healthy control subjects (4.87 for migraineurs [standard deviation (SD) = 2.74] and 3.42 for controls [SD = 1.52], P = .042). We also observed higher Glu levels (6.98 for migraineurs [SD = 0.85] and 6.22 for controls [SD = 0.97], P = .007) and Glu/creatine + phosphocreatine ratio (1.18 for migraineurs [SD = 0.18] and 1.00 for controls [SD = 0.16], P = .001) in anterior paracingulate cortex in migraine patients but saw no differences in Glu/Gln ratio (2.79 for migraineurs [SD = 1.11] and 2.63 for controls [SD = 1.61], P = .68).
CONCLUSION: These findings are consistent with glutamatergic differences in migraine patients during the interictal period compared with healthy controls. We hypothesize that an increased Glu/Gln ratio could arise from neuronal-glial coupling of glutamatergic metabolism differences or an increased neuron/astrocyte ratio in the OC.
© 2012 American Headache Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23278319     DOI: 10.1111/head.12030

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  14 in total

Review 1.  Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism.

Authors:  G D'Andrea; S Cevoli; D Colavito; A Leon
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

2.  Neurochemical metabolite alterations of the occipital lobe in migraine without aura by proton magnetic resonance spectroscopy.

Authors:  Alireza Dehghan; Erfan Saatchian; Mohammadreza Sobhani; Alireza Montazerabadi
Journal:  Neuroradiol J       Date:  2020-06-23

3.  Opposite Dynamics of GABA and Glutamate Levels in the Occipital Cortex during Visual Processing.

Authors:  Katarzyna Kurcyus; Efsun Annac; Nina M Hanning; Ashley D Harris; Georg Oeltzschner; Richard Edden; Valentin Riedl
Journal:  J Neurosci       Date:  2018-10-03       Impact factor: 6.167

4.  Acute Exposure to Pacific Ciguatoxin Reduces Electroencephalogram Activity and Disrupts Neurotransmitter Metabolic Pathways in Motor Cortex.

Authors:  Gajendra Kumar; Ngan Pan Bennett Au; Elva Ngai Yu Lei; Yim Ling Mak; Leanne Lai Hang Chan; Michael Hon Wah Lam; Leo Lai Chan; Paul Kwan Sing Lam; Chi Him Eddie Ma
Journal:  Mol Neurobiol       Date:  2016-09-10       Impact factor: 5.590

Review 5.  Advanced Imaging in the Evaluation of Migraine Headaches.

Authors:  Benjamin M Ellingson; Chelsea Hesterman; Mollie Johnston; Nicholas R Dudeck; Andrew C Charles; Juan Pablo Villablanca
Journal:  Neuroimaging Clin N Am       Date:  2019-02-19       Impact factor: 2.264

6.  A 'complex' of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patients.

Authors:  L Becerra; R Veggeberg; A Prescot; J E Jensen; P Renshaw; S Scrivani; E L H Spierings; R Burstein; D Borsook
Journal:  Neuroimage Clin       Date:  2016-03-31       Impact factor: 4.881

7.  Interictal brain activity differs in migraine with and without aura: resting state fMRI study.

Authors:  Péter Faragó; Bernadett Tuka; Eszter Tóth; Nikoletta Szabó; András Király; Gergő Csete; Délia Szok; János Tajti; Árpád Párdutz; László Vécsei; Zsigmond Tamás Kincses
Journal:  J Headache Pain       Date:  2017-01-25       Impact factor: 7.277

8.  High-field MRS study of GABA+ in patients with migraine: response to levetiracetam treatment.

Authors:  Qiang Li; Chunfu Chen; Tao Gong
Journal:  Neuroreport       Date:  2018-08-15       Impact factor: 1.837

9.  Altered Resting State Functional Activity and Microstructure of the White Matter in Migraine With Aura.

Authors:  Péter Faragó; Eszter Tóth; Krisztián Kocsis; Bálint Kincses; Dániel Veréb; András Király; Bence Bozsik; János Tajti; Árpád Párdutz; Délia Szok; László Vécsei; Nikoletta Szabó; Zsigmond Tamás Kincses
Journal:  Front Neurol       Date:  2019-10-01       Impact factor: 4.003

10.  Increased GABA+ in People With Migraine, Headache, and Pain Conditions- A Potential Marker of Pain.

Authors:  Aimie L Peek; Andrew M Leaver; Sheryl Foster; Georg Oeltzschner; Nicolaas A Puts; Graham Galloway; Michele Sterling; Karl Ng; Kathryn Refshauge; Maria-Eliza R Aguila; Trudy Rebbeck
Journal:  J Pain       Date:  2021-06-25       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.